Find an expert:

The RMC provides expertise across six domains that are critical to supporting research across the projects and the Cores to address health equity in persistent poverty areas:

·       Biostatistics (Drs. Christos and Cheung)

·       Study Design (Drs. Pinheiro, Rosenberg, Genkinger, and Tehranifar)

·       Patient-Reported Outcomes (Drs. Pinheiro and Rosenberg)

·       Data Harmonization (Dr. Genkinger)

·       Social determinants of health (Drs. Pinheiro and Tehranifar)

·       Implementation science (Drs. Cheung and Tehranifar).

  • Laura Pinheiro, PhD

    Laura Pinheiro is an Assistant Professor of Health Services Research in Medicine in the Division of General Internal Medicine at Weill Cornell Medicine in New York City. Laura completed her doctoral training the University of North Carolina at Chapel Hill in the Department of Health Policy and Management and joined faculty at Weill Cornell Medicine in 2017. At Weill Cornell, Laura works at the intersection of cancer, primary care, and racial disparities to improve health outcomes and health equity. Her work uses both quantitative and qualitative methods to develop and rigorously evaluate real-world interventions to optimize healthcare delivery for underserved cancer patients.

  • Jeanine Genkinger, PhD

    Jeanine Genkinger, PhD, is a cancer epidemiologist who has been driven to understand how modifiable factors, molecular pathways and related biomarkers may impact cancer risk and progression, particularly for rare but highly fatal cancers. Her research interests include prevention through determining modifiable risk factors and improved early detection through identifying markers of risk and molecular pathways to offer the most promising approaches to reducing morbidity and mortality of these diseases. Her area of methodological specialty is in nutritional epidemiology, longitudinal design and complex pooled and meta-analytic techniques.

  • Parisa Tehranifar, DrPH

    Parisa Tehranifar, DrPH has training in sociomedical sciences and cancer epidemiology. Dr. Tehranifar's broad research interests are in cancer health disparities and breast cancer prevention. One area of her work focuses on understanding the contribution of emerging medical interventions as a source of health disparities, and includes an ongoing study that examines the role of breast density disclosure in relation to breast cancer screening disparities.

  • Paul Christos, DrPH

    Paul J. Christos, Dr.P.H., M.S., Associate Research Professor of Population Health Sciences, received his Doctorate in Public Health (Dr.P.H.) in Epidemiology from the New York Medical College School of Public Health in 2009. In 1995, he received his Masters (M.S.) in Biostatistics and Masters (M.P.H.) in Epidemiology also from the New York Medical College School of Public Health. Prior to joining Weill Cornell Medical College in January 2000, Dr. Christos worked as a biostatistician and epidemiologist at Strang Cancer Prevention Center, and later as a biostatistician in the Dermatology Service at Memorial Sloan Kettering Cancer Center. During this time, he also served as an adjunct faculty member in the Department of Public Health, Weill Medical College, and in the Department of Health Quantitative Sciences, New York Medical College, where he taught introductory epidemiology and biostatistics to medical students and graduate students.

    Dr. Christos is the Director of the Biostatistics, Epidemiology and Research Design (BERD) Core of the Weill Cornell Clinical and Translational Science Center (CTSC). In this role, he directs the administrative structure of the BERD, in additional to his ongoing CTSC responsibilities of developing, organizing, evaluating, and teaching courses, mentoring junior investigators in writing protocols and proposals, reviewing protocols, developing new statistical methods applicable to translational science, providing analysis of data for projects through the BERD, and participating in the national Biostatistics, Epidemiology, and Research Design (BERD) consortium. He is also the lead biostatistician on two Protocol Review Monitoring Committees (PRMC) of the Weill Cornell Joint Clinical Trials Office, as well as the lead biostatistician on the Adult and Pediatric Translational Research Advisory Committees of the CTSC.

    Dr. Christos is also the Director of the Biostatistics and Epidemiology Consulting Service, based in the Division of Biostatistics. In this position, he manages and assigns divisional biostatisticians to Core consultation projects and provides support for numerous short-term and long-term projects that require data analysis, statistical writing for grants, and manuscript writing and submission. He has collaborated with nearly all of the academic departments at Weill Medical College, providing statistical analyses, sample size/power calculations, assistance with the design of studies, and assistance with manuscript preparation and submission. As a result of these consultations and collaborations, Dr. Christos has coauthored numerous publications (specifically with a strong focus in cancer research).

    He also dedicates a significant portion of his time to teaching at Weill Medical College, New York-Presbyterian Hospital, and a number of our affiliated institutions. His teaching responsibilities include instruction in epidemiological and biostatistical methods to faculty, residents, fellows, and medical students. In 2001, Dr. Christos was awarded an Award for Teaching Excellence for his outstanding efforts in teaching epidemiology and biostatistics in the medical school curriculum.

  • Kuen Cheung, PhD

    Dr. Ying Kuen K Cheung's primary research interests include experimental design, with an expertise in early phase clinical trials in cancer and stroke, both significant public health concerns especially in the aging population. Efficient statistical designs facilitate the screening of potential treatments and identification of appropriate dose ranges of treatments, while maintaining the safety of consented patients. Dr. Cheung has served on the steering committee or as an investigator in many Mailman School and Columbia-initiated and commercially-sponsored studies.

  • Shoshana Rosenberg, ScD

    Shoshana Rosenberg, ScD, MPH, is a cancer epidemiologist and health services researcher whose research focuses on survivorship, quality of life and treatment decision-making in young women with breast cancer. Dr. Rosenberg received her B.A. from Binghamton University, completed a Master of Public Health degree at NYU and a Doctor of Science degree in Epidemiology at the Harvard School of Public Health. Following an NCI post-doctoral Fellowship in Cancer Prevention, a joint program between the Harvard School of Public Health and Dana-Farber Cancer Institute, she was appointed to her current position as an Instructor at Dana-Farber and Harvard Medical School.